Based on the previous evidence, together with our results, we suggested that HMGB1 may play an important role in the mechanism promoting the systemic clinical features of patients with MIS-C and possibly also be involved in the cardiac involvement and coronary dilation of patients with MIS-C. This evidence concerns the gene HMGB1 and COVID-19–associated multisystem inflammatory syndrome in children.